PSYCHOTIC DISORDERS

This study tests a family-focused therapy program for 220 youth aged 13-25 who show early signs of psychosis risk. The therapy aims to reduce troubling symptoms and lower the chance of developing full psychosis over 18 months. Participants attend therapy sessions with a parent or…

This study looks at whether adding cognitive behavioral therapy (a type of talk therapy) to standard medication can improve symptoms and daily functioning for people with conditions like anxiety, depression, OCD, PTSD, bipolar disorder, schizophrenia, and personality disorders. A…

This study tests a 10-session talking therapy designed to help people with recent-onset psychosis better understand and accept their medication. Researchers will compare medication adherence and attitudes toward treatment between those who receive the therapy plus usual care and …

This study tests a program where trained peer support workers help adults who recently had their first episode of psychosis. The program focuses on self-care and recovery skills. Researchers will follow 198 participants for 18 months to see if it improves their recovery and daily…

This study tests a therapy called imagery rescripting in 8 people with early psychosis. The goal is to see if it helps change negative core beliefs and improve wellbeing and self-esteem. Participants receive 4-6 therapy sessions over a few weeks and are followed for 3 more weeks.…

This study tested whether resilience training delivered in a multi-user virtual reality setting is practical and well-received by people with mood, anxiety, or psychotic disorders. Researchers measured discomfort with others, emotion recognition, and personal space preferences. T…

This study aims to collect DNA, brain images, and other biological samples from 2,000 people with major depression, bipolar disorder, or psychotic disorders, as well as healthy volunteers. By analyzing these samples, researchers hope to find physical and genetic factors that can …

This study looks at how cannabinoids (the active chemicals in cannabis) affect short-term and long-term memory. Researchers will test memory in 80 adults aged 18–55 who have used cannabis at least once. The goal is to understand, not to treat, so no new therapies are being tested…